Tonix Pharmaceuticals HoldingTNXP +3.04%39 Days Inventory is 337.07 as of Mar. 2026, which is 36% below its 10-year median of 530.11. GuruFocus rates TNXP with a GF Score™ of 39/100 and a GF Value™ of $1.75 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 635 Biotechnology companies, Tonix Pharmaceuticals Holding ranks worse than 70.24% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Tonix Pharmaceuticals Holding's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Tonix Pharmaceuticals Holding's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.85.
Tonix Pharmaceuticals Holding (NAS:TNXP) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Tonix Pharmaceuticals Holding's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Tonix Pharmaceuticals Holding's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Tonix Pharmaceuticals Holding Days Inventory Related Terms
Tonix Pharmaceuticals Holding Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tonix Pharmaceuticals Holding Days Inventory Chart
TNXP vs ALEC, IMUX, WHWK: Days Inventory Comparison
For the Biotechnology subindustry, Tonix Pharmaceuticals Holding's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tonix Pharmaceuticals Holding Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tonix Pharmaceuticals Holding's Days Inventory distribution charts can be found below:
* The bar in red indicates where Tonix Pharmaceuticals Holding's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tonix Pharmaceuticals Holding (TNXP) has a Days Inventory of 337.07 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Tonix Pharmaceuticals Holding and its competitors. This is 36% below median its historical median of 530.11. Over the past decade, Tonix Pharmaceuticals Holding's Days Inventory has ranged from 316.17 to 1,089.15. According to the industry distribution chart, Tonix Pharmaceuticals Holding ranks #446 out of 635 companies in the Biotechnology industry, placing it in the top 70.2%.
Is Tonix Pharmaceuticals Holding's Days Inventory too high?
Tonix Pharmaceuticals Holding's current Days Inventory of 337.07 is 36% below median its 10-year median of 530.11. Over the past 10 years, this metric has ranged from a low of 316.17 to a high of 1,089.15. The Biotechnology industry median Days Inventory is 183.23. Tonix Pharmaceuticals Holding's value of 337.07 is 84% above this industry median. Based on the distribution chart, Tonix Pharmaceuticals Holding ranks #446 out of 635 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Tonix Pharmaceuticals Holding has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tonix Pharmaceuticals Holding's Days Inventory compare to ALEC and IMUX?
According to the Biotechnology industry distribution chart, Tonix Pharmaceuticals Holding ranks #446 out of 635 companies for Days Inventory. This places Tonix Pharmaceuticals Holding in the lower half of its industry. The industry median Days Inventory is 183.23. Tonix Pharmaceuticals Holding's value of 337.07 is 84% above this benchmark. Historically, Tonix Pharmaceuticals Holding's own Days Inventory has ranged from 316.17 to 1,089.15 over the past decade. While the company's 10-year median is 530.11 vs. the industry median of 183.23, Tonix Pharmaceuticals Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tonix Pharmaceuticals Holding's current Days Inventory of 337.07 is 84% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Tonix Pharmaceuticals Holding and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tonix Pharmaceuticals Holding's current Days Inventory is 337.07, which is 36% below median its own 10-year median of 530.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tonix Pharmaceuticals Holding stock overvalued right now?
Based on GuruFocus' analysis, Tonix Pharmaceuticals Holding (TNXP) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.75, compared to a current price of $12.72 — trading 626.6% above its estimated fair value. The current Days Inventory is 337.07, which is 36% below median its 10-year median of 530.11 and 84% above the Biotechnology industry median of 183.23. Tonix Pharmaceuticals Holding's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Tonix Pharmaceuticals Holding (TNXP), the current Days Inventory is 337.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tonix Pharmaceuticals Holding (TNXP) Overvalued in 2026?
Based on GuruFocus' analysis, Tonix Pharmaceuticals Holding stock appears to be overvalued.
The current stock price of $12.72 is trading 626.6% above its estimated GF Value™ of $1.75.
GuruFocus considers Tonix Pharmaceuticals Holding to be Significantly Overvalued.
Key valuation signals for TNXP:
Days Inventory: 337.07 (36% below median its 10-year median of 530.11)
GF Value™: $1.75 vs. price of $12.72 (626.6% above fair value)
Industry Position: 84% above the Biotechnology median (#446 of 635)
No single metric tells the full story. See the TNXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tonix Pharmaceuticals Holding Business Description
Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.
39GF Score
Get the complete analysis for TNXP
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TNXP has been successfully added to your 
